NASDAQ:ALKS
$29.02
(
1.82%
)
Friday, 27th Jan 2023
Alkermes plc Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $24.91 | $29.05 | Friday, 27th Jan 2023 ALKS stock ended at $29.02. This is 1.82% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.93% from a day low at $28.50 to a day high of $29.05. |
| 90 days | $22.09 | $29.05 | |
| 52 weeks | $21.75 | $32.79 |
Historical Alkermes plc prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $28.62 | $29.05 | $28.50 | $29.02 | 1 162 351 |
| 2023-01-26 | $28.31 | $28.55 | $28.16 | $28.50 | 1 037 067 |
| 2023-01-25 | $27.95 | $28.58 | $27.95 | $28.34 | 1 661 852 |
| 2023-01-24 | $27.17 | $27.98 | $27.05 | $27.98 | 844 400 |
| 2023-01-23 | $27.60 | $27.71 | $27.13 | $27.34 | 1 638 303 |
| 2023-01-20 | $28.13 | $28.82 | $27.69 | $27.72 | 1 932 905 |
| 2023-01-19 | $27.56 | $28.02 | $27.38 | $27.89 | 1 587 800 |
| 2023-01-18 | $28.68 | $28.68 | $27.61 | $27.66 | 1 816 816 |
| 2023-01-17 | $27.94 | $28.62 | $27.26 | $28.54 | 2 391 600 |
| 2023-01-13 | $27.46 | $27.61 | $27.02 | $27.31 | 1 334 209 |
| 2023-01-12 | $26.75 | $27.58 | $26.56 | $27.56 | 1 351 224 |
| 2023-01-11 | $27.02 | $27.02 | $26.24 | $26.84 | 1 422 000 |
| 2023-01-10 | $26.21 | $27.24 | $26.03 | $27.09 | 1 787 319 |
| 2023-01-09 | $27.01 | $27.22 | $25.87 | $26.14 | 2 065 410 |
| 2023-01-06 | $26.35 | $27.65 | $26.09 | $27.11 | 2 177 700 |
| 2023-01-05 | $25.28 | $25.42 | $25.00 | $25.31 | 696 357 |
| 2023-01-04 | $25.94 | $26.15 | $25.12 | $25.33 | 1 200 846 |
| 2023-01-03 | $26.13 | $26.33 | $25.77 | $25.87 | 1 005 658 |
| 2022-12-30 | $26.15 | $26.21 | $25.73 | $26.13 | 799 104 |
| 2022-12-29 | $25.35 | $26.34 | $25.24 | $26.24 | 1 229 620 |
| 2022-12-28 | $25.18 | $25.50 | $24.91 | $25.26 | 1 126 530 |
| 2022-12-27 | $25.47 | $25.64 | $25.13 | $25.19 | 791 480 |
| 2022-12-23 | $25.49 | $25.89 | $25.33 | $25.49 | 1 057 002 |
| 2022-12-22 | $25.83 | $25.97 | $25.52 | $25.61 | 1 055 341 |
| 2022-12-21 | $25.81 | $26.23 | $25.53 | $25.98 | 835 536 |
| 2022-12-20 | $25.13 | $25.88 | $25.13 | $25.72 | 943 027 |
| 2022-12-19 | $25.56 | $25.60 | $24.80 | $25.24 | 1 142 021 |
| 2022-12-16 | $24.82 | $25.60 | $24.69 | $25.52 | 2 185 745 |
| 2022-12-15 | $25.62 | $25.62 | $25.00 | $25.09 | 1 049 222 |
| 2022-12-14 | $25.32 | $25.83 | $25.03 | $25.62 | 1 147 328 |
| 2022-12-13 | $25.38 | $25.70 | $24.96 | $25.54 | 1 683 366 |
| 2022-12-12 | $24.63 | $25.37 | $24.51 | $25.28 | 3 870 890 |
| 2022-12-09 | $25.42 | $25.48 | $24.68 | $24.70 | 1 010 564 |
| 2022-12-08 | $25.37 | $25.72 | $25.16 | $25.48 | 753 976 |
| 2022-12-07 | $25.16 | $25.32 | $24.82 | $25.27 | 1 306 988 |
| 2022-12-06 | $25.28 | $25.33 | $24.79 | $25.00 | 822 757 |
| 2022-12-05 | $26.05 | $26.07 | $25.33 | $25.51 | 1 095 352 |
| 2022-12-02 | $25.13 | $26.17 | $24.85 | $26.09 | 1 978 496 |
| 2022-12-01 | $24.89 | $25.38 | $24.72 | $25.20 | 1 158 936 |
| 2022-11-30 | $24.21 | $24.82 | $23.96 | $24.78 | 1 561 556 |
| 2022-11-29 | $24.00 | $24.33 | $23.71 | $24.02 | 1 013 699 |
| 2022-11-28 | $24.22 | $24.39 | $23.82 | $23.97 | 1 255 403 |
| 2022-11-25 | $24.28 | $24.52 | $24.11 | $24.20 | 652 814 |
| 2022-11-23 | $24.53 | $24.73 | $24.02 | $24.27 | 2 457 396 |
| 2022-11-22 | $24.01 | $24.79 | $23.94 | $24.50 | 2 217 903 |
| 2022-11-21 | $23.52 | $23.73 | $23.19 | $23.71 | 501 240 |
| 2022-11-18 | $22.90 | $23.66 | $22.81 | $23.35 | 833 105 |
| 2022-11-17 | $22.68 | $23.14 | $22.31 | $22.41 | 1 161 040 |
| 2022-11-16 | $22.60 | $22.66 | $22.09 | $22.51 | 585 906 |
| 2022-11-15 | $23.11 | $23.13 | $22.40 | $22.67 | 1 241 179 |
About Alkermes plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre... ALKS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
